Jeffrey Eisele - Jan 27, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Development Officer
Signature
/s/ David Watson, attorney-in-fact for Jeffrey Eisele
Stock symbol
APLS
Transactions as of
Jan 27, 2023
Transactions value $
-$19,367
Form type
4
Date filed
1/30/2023, 03:58 PM
Previous filing
Jan 25, 2023
Next filing
Jan 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability -$19.4K -367 -0.77% $52.77 47.4K Jan 27, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares withheld for tax on a restricted stock unit release.